We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - Yes
MULTIPLE SCLEROSIS JOURNAL (2019)
Journal
MULTIPLE SCLEROSIS JOURNAL
Volume 25, Issue 2, Pages 187-188Publisher
SAGE PUBLICATIONS LTD
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Antioxidants in Pregnancy: Do We Really Need More Trials?
Carolina Di Fabrizio, Veronica Giorgione, Asma Khalil, Colin E. Murdoch
ANTIOXIDANTS (2022)
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them
Philip R. Krause, Thomas R. Fleming, Ira M. Longini, Richard Peto, Valerie Beral, Balram Bhargava, Alejandro Cravioto, Jakob P. Cramer, Susan S. Ellenberg, J. Peter Figueroa, Elizabeth Halloran, Ana M. Henao-Restrepo, Michael J. Ryan, Myron M. Levine, Martha Nason, Hanna M. Nohynek, Stanley Plotkin, Helen Rees, Jerome A. Singh, Soumya Swaminathan
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Automating Uniformity Trials to Optimize Precision of Agronomic Field Trials
Marcus Jones, Marin Harbur, Ken J. Moore
AGRONOMY-BASEL (2021)
Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?
Elizabeth J. de Koster, Taban Sulaiman, Jaap F. Hamming, Abbey Schepers, Marieke Snel, Floris H. P. van Velden, Lioe-Fee de Geus-Oei, Dennis Vriens
DIAGNOSTICS (2021)
We need to talk about nonprobability samples
Robin J. Boyd, Gary D. Powney, Oliver L. Pescott
TRENDS IN ECOLOGY & EVOLUTION (2023)
Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials
Muhammad Shahzeb Khan, Muhammad Shariq Usman, Khawaja M. Talha, Harriette G. C. Van Spall, Stephen J. Greene, Muthiah Vaduganathan, Sadiya S. Khan, Nicholas L. Mills, Ziad A. Ali, Robert J. Mentz, Gregg C. Fonarow, Sunil Rao, John A. Spertus, Matthew T. Roe, Stefan D. Anker, Stefan K. James, Javed Butler, Darren K. McGuire
EUROPEAN HEART JOURNAL (2023)
We need to talk about engineering policy
Adam C. G. Cooper, Laurent Liote, Chloe Colomer
TECHNOLOGY IN SOCIETY (2023)
Can we build it? Yes, we can! complexities of resource re-deployment to fight pandemic.
Ziad Elsahn, Frank Siedlok
INDUSTRIAL MARKETING MANAGEMENT (2021)
We need to think more about how we conduct research Comment
Gerd Gigerenzer
BEHAVIORAL AND BRAIN SCIENCES (2022)
Psychedelics therapeutics: What we know, what we think, and what we need to research
David Nutt, Meg Spriggs, David Erritzoe
NEUROPHARMACOLOGY (2023)
Corporate social irresponsibility: What we know and what we need to know
Maria Iborra, Marta Riera
CORPORATE SOCIAL RESPONSIBILITY AND ENVIRONMENTAL MANAGEMENT (2023)
We need to talk about intermittent demand forecasting
Konstantinos Nikolopoulos
EUROPEAN JOURNAL OF OPERATIONAL RESEARCH (2021)
Disease modifying therapy and pregnancy outcomes in multiple sclerosis: A systematic review and meta-analysis
Erum Khan, Yusuf Kagzi, Mahmoud Elkhooly, Swapnil Surpur, Sijin Wen, Kanika Sharma, Shitiz Sriwastava
JOURNAL OF NEUROIMMUNOLOGY (2023)
We need to chat about artificial intelligence
Enrico W. Coiera, Karin Verspoor, David P. Hansen
MEDICAL JOURNAL OF AUSTRALIA (2023)
Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
Mahendra Rai, Avinash P. Ingle, Joanna Trzcinska-Wencel, Magdalena Wypij, Shital Bonde, Alka Yadav, Gabriela Kratosova, Patrycja Golinska
NANOMATERIALS (2021)
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
Maria Pia Amato, Tobias Derfuss, Bernard Hemmer, Roland Liblau, Xavier Montalban, Per Soelberg Sorensen, David H. Miller
MULTIPLE SCLEROSIS JOURNAL (2018)
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
Nicholas G. LaRocca, Lynn D. Hudson, Richard Rudick, Dagmar Amtmann, Laura Balcer, Ralph Benedict, Robert Bermel, Ih Chang, Nancy D. Chiaravalloti, Peter Chin, Jeffrey A. Cohen, Gary R. Cutter, Mat D. Davis, John DeLuca, Peter Feys, Gordon Francis, Myla D. Goldman, Emily Hartley, Raj Kapoor, Fred Lublin, Gary Lundstrom, Paul M. Matthews, Nancy Mayo, Richard Meibach, Deborah M. Miller, Robert W. Motl, Ellen M. Mowry, Rob Naismith, Jon Neville, Jennifer Panagoulias, Michael Panzara, Glenn Phillips, Ann Robbins, Matthew F. Sidovar, Kathryn E. Smith, Bjorn Sperling, Bernard M. J. Uitdehaag, Jerry Weaver
MULTIPLE SCLEROSIS JOURNAL (2018)
Multiple sclerosis relapse: Qualitative findings from clinician and patient interviews
Louis S. Matza, Katherine Kim, Glenn Phillips, Kelsey Zorn, Kitty S. Cha, Katherine C. Smith, Ellen M. Mowry
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness
Angeliki Filippatou, Thomas Shoemaker, Megan Esch, Madiha Qutab, Natalia Gonzalez-Caldito, Jerry L. Prince, Ellen M. Mowry, Peter A. Calabresi, Shiv Saidha, Elias S. Sotirchos
MULTIPLE SCLEROSIS JOURNAL (2019)
Retinal measurements predict 10-year disability in multiple sclerosis
Alissa Rothman, Olwen C. Murphy, Kathryn C. Fitzgerald, Julia Button, Eliza Gordon-Lipkin, John N. Ratchford, Scott D. Newsome, Ellen M. Mowry, Elias S. Sotirchos, Stephanie B. Syc-Mazurek, James Nguyen, Natalia Gonzalez Caldito, Laura J. Balcer, Elliot M. Frohman, Teresa C. Frohman, Daniel S. Reich, Ciprian Crainiceanu, Shiv Saidha, Peter A. Calabresi
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes
Pavan Bhargava, Kathryn C. Fitzgerald, Swarajya L. V. Venkata, Matthew D. Smith, Michael D. Kornberg, Ellen M. Mowry, Norman J. Haughey, Peter A. Calabresi
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders
Olga Ciccarelli, Jeffrey A. Cohen, Stephen C. Reingold, Brian G. Weinshenker, Maria Pia Amato, Brenda Banwell, Frederik Barkhof, Bruce Bebo, Burkhard Becher, Francois Bethoux, Alexander Brandt, Wallace Brownlee, Peter Calabresi, Jeremy Chatway, Claudia Chien, Tanuja Chitnis, Olga Ciccarelli, Jeffrey Cohen, Giancarlo Comi, Jorge Correale, Jerome De Seze, Nicola De Stefano, Franz Fazekas, Eoin Flanagan, Mark Freedman, Kazuo Fujihara, Steven Galetta, Myla Goldman, Benjamin Greenberg, Hans-Peter Hartung, Bernhard Hemmer, Anke Henning, Izlem Izbudak, Ludwig Kappos, Hans Lassmann, Cornelia Laule, Michael Levy, Fred Lublin, Claudia Lucchinetti, Carsten Lukas, Ruth Ann Marrie, Aaron Miller, David Miller, Xavier Montalban, Ellen Mowry, Sebastien Ourselin, Friedemann Paul, Daniel Pelletier, Jean-Philippe Ranjeva, Daniel Reich, Stephen Reingold, Maria Assunta Rocca, Alex Rovira, Regina Schlaerger, Per Soelberg Sorensen, Maria Sormani, Olaf Stuve, Alan Thompson, Mar Tintore, Anthony Traboulsee, Bruce Trapp, Maria Trojano, Bernard Uitdehaag, Sandra Vukusic, Emmanuelle Waubant, Brian Weinshenker, Claudia Gandini Wheeler-Kingshott, Junqian Xu
LANCET NEUROLOGY (2019)
Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis
Elias S. Sotirchos, Natalia Gonzalez-Caldito, Blake E. Dewey, Kathryn C. Fitzgerald, Jeffrey Glaister, Angeliki Filippatou, Esther Ogbuokiri, Sydney Feldman, Ohemaa Kwakyi, Hunter Risher, Ciprian Crainiceanu, Dzung L. Pham, Peter C. Van Zijl, Ellen M. Mowry, Daniel S. Reich, Jerry L. Prince, Peter A. Calabresi, Shiv Saidha
MULTIPLE SCLEROSIS JOURNAL (2020)
Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes
Kathryn C. Fitzgerald, Amber Salte, Tuula Tyry, Robert J. Fox, Gary Cutte, Ellen M. Mowry, Ruth Ann Marrie
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement
Pavan Bhargava, Cassie Wicken, Matthew D. Smith, Roy E. Strowd, Irene Cortese, Daniel S. Reich, Peter A. Calabresi, Ellen M. Mowry
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
The prevalence and utility of screening for urinary tract infection at the time of presumed multiple sclerosis relapse
Kathryn C. Fitzgerald, Lydia A. Cassard, Samantha Roman Fox, John C. Probasco, Sandra D. Cassard, Ellen M. Mowry
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Conducting dietary intervention trials in people with multiple sclerosis: Lessons learned and a path forward
Kathryn C. Fitzgerald, Ilana Katz Sand, Angela Senders, Rebecca Spain, Barbara Giesser, Patrick Sullivan, David J. Baer, Nicholas LaRocca, Kathleen Zackowski, Ellen M. Mowry
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Safety and feasibility of various fasting -mimicking diets among people with multiple sclerosis
S. N. Roman, K. C. Fitzgerald, M. Beier, E. M. Mowry
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis
Yujie Wang, Fan Tian, Kathryn C. Fitzgerald, Jagriti Jackie Bhattarai, Robert T. Naismith, Megan Hyland, Peter A. Calabresi, Ellen M. Mowry
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)